When a rapid toxicology test yields a positive result, the next step is crucial—confirmation through laboratory testing. While rapid tests provide quick insights, they can sometimes lead to false positives or incomplete data, impacting critical decisions in healthcare, workplace safety, and legal settings. This webinar will explore the importance of lab confirmations, the science behind definitive testing methods, and the potential consequences of relying solely on preliminary results.
Join us for an exclusive webinar uncovering the DEA’s 2024 Emerging Drug Threats and Trends Report. Gain crucial insights into the latest drug trends impacting communities across the United States. Learn about evolving substances, public health concerns, and how these issues shape enforcement and prevention strategies. Stay informed and prepared and don’t miss this opportunity to understand the critical challenges and solutions shaping our fight against drug abuse.
Join our Chief Product Officer, Eric Malis, as he delves into the world of Kratom in this live recorded educational webinar. Gain key insights into its usage trends, potential effects, legal challenges, and advancements in drug testing. This is a must watch for anyone seeking clarity on this controversial substance.
Join our Chief Product Officer, Eric Malis for another in-depth webinar on Nitazines, a potent and emerging class of synthetic opioids. We’ll explore current trends in Nitazine usage, the challenges in detecting and testing for these substances, and the latest screening methods, as well as, the significant threat they pose to public health. This session is crucial for healthcare professionals and policymakers to understand the growing impact of Nitazines and develop effective strategies to address the rise in use.
In this live recorded webinar, we delve into the pressing topic of Fentanyl, other Opioids, usage, myths and the current state of the ongoing opioid crisis. Our Chief Product Officer, Eric Malis, will provide insights into these substances, including their impact on public health, trends in usage, regulatory measures, and innovative approaches to address the crisis. From the latest statistics to potential solutions, this webinar promises a comprehensive exploration of one of today’s most urgent public health challenges.
In this insightful live recorded webinar, we delve into the world of hallucinogens from a point of care toxicology testing standpoint. We will explore various types of hallucinogens, their effects on the mind and body, and the challenges they present in regard to toxicology screening. Our Chief Product Officer, Eric Malis, will discuss current testing methods, limitations, and future advancements in this field. Whether you’re a healthcare professional, researcher, or simply have an interest in the subject, this webinar promises to provide valuable knowledge and perspective.
